Showing results (1-10 of 615) with videos related to
Sort By:
Pageof 62
Current Protocols in Pharmacology|October 1, 2011
Characterization of 5-HT(₁A,B) and 5-HT(₂A,C) serotonin receptor bindingW P Clarke, K A Berg, G Gould, et al.Brain Research Bulletin|December 26, 2001
Regulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascadesK A Berg, W P ClarkeMolecular Pharmacology|October 1, 1996
5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolismK A Berg, S Maayani, W P ClarkeAnnals of the New York Academy of Sciences|February 3, 1999
Interactions between effectors linked to serotonin receptorsK A Berg, S Maayani, W P ClarkeAnnals of the New York Academy of Sciences|February 3, 1999
Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonistsK A Berg, S Maayani, J Goldfarb, et al.Journal of Neurochemistry|January 1, 1995
Nerve growth factor amplifies cyclic AMP production in the HT4 neuronal cell lineK A Berg, S Maayani, R McKay, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activationK A Berg, B D Stout, S Maayani, et al.Molecular Pharmacology|September 1, 1994
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systemsK A Berg, W P Clarke, C Sailstad, et al.The Journal of Pharmacology and Experimental Therapeutics|May 18, 2001
Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling componentsK L Evans, J D Cropper, K A Berg, et al.Molecular Pharmacology|July 11, 1998
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulusK A Berg, S Maayani, J Goldfarb, et al.Pageof 62